NASHVILLE, Tenn.–(BUSINESS WIRE)–Susan G. Komen®, the world’s leading breast cancer organization, commends Representative Rick Scarbrough (R-Oak Ridge) and Senator Richard Briggs (R-Knoxville) for introducing legislation that would eliminate financial barriers for patients requiring clinically appropriate genetic testing, as well as the recommended screenings based on the results of that testing. Germline testing is a type of test that looks for inherited mutations that have been present in every cell of the body since birth. In the U.S., 5-10% of breast cancers are related to a known inherited gene mutation. The lifetime risk of breast cancer increases 20-49% for women with…
